Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) Deal History & Licensing Activity
Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) is a life sciences. Over the past three years, Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Small Molecules
Focus Area
Infectious Disease
Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Cabotegravir long-acting injectable | ViiV Healthcare | Small Molecules | Approved | license | Jun 2025 |
Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) Pipeline Focus
Therapeutic areas and modalities where Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris)'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) Licensing & Deal Activity
Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) include Infectious Disease (2 deals and trials). In terms of modality, Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris) and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Medicines Patent Pool (MPP) / generic licensees (Aurobindo, Cipla, Viatris)'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.